Instrument Inactif

Autres langues CRUCELL

Actions

NL0000358562

Cours en clôture Euronext Amsterdam Autres places de cotation
- ^EUR	-

2011	Crucell : feu vert de la Commission à l'OPA.	CF
2010	Crucell : en hausse avant l'OPA de Johnosn & Johnson.	CF

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Crucell N.V. : JUDGMENT ISSUED IN CRUCELL N.V. BUY-OUT PROCEEDINGS	28/02/12
CRUCELL : JUDGMENT ISSUED IN CRUCELL N.V. BUY-OUT PROCEEDINGS	28/02/12
CRUCELL : Discovers Important New Antibody Against Influenza A	07/07/11
CRUCELL : Intends to Delist Ordinary Shares on NYSE Euronext	15/03/11
CRUCELL : Johnson & Johnson Acquires 98.89% of Issued Crucell Shares as of the End of the Subsequent Offering Period and Crucell Intends to Delist Crucell Ordinary Shares and ADSs	08/03/11
CRUCELL : Johnson & Johnson Completes Tender Offer for Crucell and Declares Offer Unconditional	22/02/11
CRUCELL : Minimum Acceptance Condition Satisfied	17/02/11
CRUCELL : Shareholders Adopt Offer Governance Resolutions and Johnson & Johnson Makes Announcement on U.S. Regulatory Matters	08/02/11
CRUCELL : Reports Fourth Quarter and Full Year 2010 Results	07/02/11
CRUCELL : Johnson & Johnson Launches Recommended Public Offer to Acquire Crucell	08/12/10
CRUCELL : Johnson & Johnson and Crucell Progress Update: Expect to Commence Public Offer Prior to 10 December 2010	30/11/10
CRUCELL : Reports Third Quarter 2010 Results	09/11/10
CRUCELL : Johnson & Johnson and Crucell Provide Progress Update on Preparations for Public Offer	29/10/10
CRUCELL : Notice of Extraordinary General Meeting of Shareholders	29/10/10
CRUCELL : Puts Temporary Hold on Shipments of Quinvaxem and Hepavax-Gene	28/10/10
CRUCELL : to Convene Initial Informational Extraordinary General Meeting of Shareholders to Discuss Johnson & Johnson Offer	14/10/10
CRUCELL : Johnson & Johnson and Crucell Reach Agreement on Intended Public Offer of ?24.75 per Ordinary Share of Crucell	06/10/10
CRUCELL : Aeras and Crucell Announce Phase II Clinical Trial Start in Kenya	22/09/10
CRUCELL : Johnson & Johnson and Crucell in advanced negotiations for an all cash public offer of EUR24.75 per ordinary share of Crucell	17/09/10
CRUCELL : Reports Record Revenues in Second Quarter 2010	17/08/10

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues CRUCELL

Actions

NL0000358562

Autres langues

Filtres